EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
78 hedge funds and large institutions have $220M invested in Eiger BioPharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $215M → $220M (+$4.1M)
Holders
78
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$15.5M | |
| 2 | +$13.5M | |
| 3 | +$12.2M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$10.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.77M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$4.87M | |
| 3 | -$2.97M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.59M |
| 5 |
Barclays
London,
United Kingdom
|
-$585K |